BRECUR AIRMASTER
50MCG/250MCG INH PLV DOS 1X60DÁV
Maximum ex-factory price/Ex-factory price ? | 602,83 CZK |
---|---|
Legal basis of maximum ex-factory price/ex-factory price ? | Maximum ex-factory price announced under the law. |
Informace o základní úhradě
Preliminarily effective core reimbursement from health insurance ? | 320,68 CZK |
---|---|
Preliminarily effective maximum reimbursement from health insurance ? | 473,71 CZK |
Legal basis of reimbursement from health insurance ? | Reimbursement set by the law. Rozhodnutí dosud nenabylo právní moci, je však předběžně vykonatelné. |
Indication restriction of reimbursement ? | Léčba inhalační fixní kombinací salmeterol/flutikason je hrazena u nemocných s diagnózou perzistující asthma bronchiale tam, kde není možno dosáhnout a trvale udržet astma pod kontrolou podáváním inhalačního kortikosteroidu v nízké dávce a při dobré spolupráci pacienta. |
Prescribing doctor's specialisation ? |
Pneumology and ftizeology, pediatric pneumology Allergology and clinical immunology |
Reporting limit ? | E: Unless it is advisable to transfer the prescription of the product to another doctor under paragraph 2 in light of the effect and safety of the product, the "E" symbol will mark the product in the decision. |
Rough price for the final consumer ? | 854,04 CZK |
Rough payment for the final consumer (for 1 prescribed package dispensed) ? | 380.33 CZK |
Eligible extra payment ? | – |
Eligible extra payment for individuals aged 65 and older ? | – |